Correlations between Lipid Levels and Age, Gender, Glycemia, Obesity, Diabetes, and Smoking

Endocrine Research

Volumn 30, Issue 1, 2004, Pages 83-93

  Devroey, Dirk ^a   De Swaef, Nick ^a   Coigniez, Peter ^a   Vandevoorde, Jan ^a   Kartounian, Jan ^a   Betz, Willem ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Belgium; Cardiovascular diseases; Cholesterol; General practice; HDL; Lipoproteins; Treatment target levels

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; FEMALE; HUMAN; HYPERGLYCEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SEX DIFFERENCE;

AGED; BELGIUM; BODY WEIGHT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GENDER IDENTITY; HUMANS; LIFE STYLE; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SMOKING;

EID: 1842429212     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-120029887     Document Type: Article

References (18)

1. Burke GL, Arnold AM, Bild DE, Cushman M, Fried LP, Newman A, Nunn C, Robbins J, CHS Collaborative Research Group. Factors associated with healthy aging: the cardiovascular health study. J Am Geriatr Soc 2001; 49(3):254-262.
2. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V. Helsinki Heart Study Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 1987; 317(20):1237-1245.
3. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988; 8:737-741.
4. Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease. Am J Cardiol 1995; 76:C69-C77.
5. Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 2001; 18:786-796.
6. Mikhailidis DP, Wierzbicki AS. HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin. Curr Med Res Opin 2000; 16:139-146.
7. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 341(6):410-418.
8. Gagne C, Bays HE, Weiss SR, Mata P, Quinto K, Melino M, Cho M, Musliner TA, Gumbiner B, Ezetimibe Study Group. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002; 90(10):1084-1091.
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
10. Miyata G, Meguid MM, Fetissov SO, Torelli GF, Kim HJ. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery 1999; 126:255-263.
11. Forde OH, Thelle DS, Arnesen E, Mjos OD. Distribution of high density lipoprotein cholesterol according to relative body weight, cigarette smoking and leisure time physical activity. The Cardiovascular Disease Study in Finnmark 1977. Acta Med Scand 1986; 219:167-171.
12. Steyn K, Fourie J, Benade AJ, Rossouw JE, Langenhoven ML, Joubert G, Chalton DO. Factors associated with high density lipoprotein cholesterol in a population with high density lipoprotein cholesterol levels. Arteriosclerosis 1989; 9(3):390-397.
13. Tuomilehto J, Tanskanen A, Salonen JT, Nissinen A, Koskela K. Effects of smoking and stopping smoking on serum high-density lipoprotein cholesterol levels in a representative population sample. Prev Med 1986; 15:35-45.
14. Shaper AG, Wannamethee SG, Walker M. Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ 1997; 314:1311-1317.
15. Gueli N, Del Nero A, Zia N, Carmenini E, Cacciafesta M. An assessment of the main metabolic variables of cardiovascular risk in a sample population of workers in Rome. Panminerva Med 2001; 43:267-277.
16. Sartorio A, Lafortuna CL, Vangeli V, Tavani A, Bosetti C, La Vecchia C. Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program. Eur J Clin Nutr 2001; 55:865-869.
17. Antonicelli R, Gesuita R, Boemi M, Paciaroni E, Camerano Study Group. Random fasting hyperglycemia as cardiovascular risk factor in the elderly: a 6-year longitudinal study. Clin Cardiol 2001; 24:341-344.
18. Senti M, Elosua R, Tomas M, Sala J, Masia R, Ordovas JM, Shen H, Marrugat J. Physical activity modulates the combined effect of a common variant of the lipoprotein lipase gene and smoking on serum triglyceride levels and high-density lipoprotein cholesterol in men. Hum Genet 2001; 109:385-392.